Vigorous Exercise Does Not Increase Long QTS-Associated Cardiac Event Rate

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on July 31, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, July 31, 2024 -- For individuals with phenotypic or genotypic long-QT syndrome (LQTS), LQTS-associated cardiac event rates are low and do not differ for those exercising vigorously or nonvigorously, according to a study published online July 25 in Circulation.

Rachel Lampert, M.D., from the Yale School of Medicine in New Haven, Connecticut, and colleagues enrolled individuals aged 8 to 60 years with phenotypic or genotypic LQTS from 37 sites in five countries in the National Institutes of Health-funded LIVE-LQTS study. Participants or parents answered questions about physical activity and clinic event surveys every six months for three years to examine whether vigorous exercise increases the risk for ventricular arrhythmias. Data were included for 1,413 participants, 52 percent of whom participated in vigorous exercise (55 percent competitively).

The researchers found that 37 individuals experienced the composite end point of sudden death, sudden cardiac arrest, ventricular arrhythmia treated by an implantable cardioverter defibrillator, and likely arrhythmic syncope, with overall event rates of 2.6 and 2.7 percent at three years in the vigorous and nonvigorous exercise groups, respectively. For the vigorous group versus the nonvigorous group, the unadjusted hazard ratio for experience of events was 0.97 (95 percent confidence interval, 0.57 to 1.67) and the adjusted hazard ratio was 1.17 (95 percent confidence interval, 0.67 to 2.04). In none of the groups or subgroups was vigorous or nonvigorous exercise found to be superior.

"These data can inform individualized shared decision-making conversations between patients and physicians on vigorous exercise participation in the context of overall expert assessment and management of LQTS," the authors write.

Several authors disclosed ties to the pharmaceutical and medical device industries.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-08-01 03:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords